Prebiotics Progress Shifts in the Intestinal Microbiome That Benefits Patients with Type 2 Diabetes Mellitus

Hypoglycemic medications that could be co-administered with prebiotics and functional foods can potentially reduce the burden of metabolic diseases such as Type 2 Diabetes Mellitus (T2DM). The efficacy of drugs such as metformin and sulfonylureas can be enhanced by the activity of the intestinal mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitetta, Luis, Gorgani, Nick N., Vitetta, Gemma, Henson, Jeremy D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526165/
https://www.ncbi.nlm.nih.gov/pubmed/37759707
http://dx.doi.org/10.3390/biom13091307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526165/
https://www.ncbi.nlm.nih.gov/pubmed/37759707
http://dx.doi.org/10.3390/biom13091307

Ejemplares similares